But unfortunately, similar to CD1c+ mDCs, the FACS results showed that pDCs percentage (0.26±0.04%, Figure 1f) among PBMCs from ESCC patients was also significantly depressed compared to healthy control (0.42±0.06%, Figure 1f). The gene discussed is CD1C; the disease is esophageal squamous cell carcinoma.